Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
778.50
Change Change %
-2.10 -0.27%

Updated:16 Nov, 2018, 14:24 PM IST

BSE
776.00
Change Change %
-4.20 -0.54%

Updated:16 Nov, 2018, 14:52 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Credit Suisse
N/A
03-05-2016 Buy 792.20 950.00
N/A
Closed Long (1Y)
03-05-2017

Credit Suisse maintains outperform on Aurobindo Pharma

Company will be a beneficiary of faster approvals in US. Margin expansion will be driven by improving product mix. Expect 38 per cent profit growth over next 2 quarters. Expect operating profit CAGR of 22 per cent over FY2016-18. Auro Pharma is favourably placed on growth and return against its peers.

Top